A report by Dr. Gouri B. Diwadkar et al. (2009) published in Obstetrics and Gynecology has found that rates of complication with the use of transvaginal mesh products is unacceptably high, reaching levels of more than 19%.[1]

Retrospectively analyzing previously-published studies of the safety and efficacy of transvaginal mesh that used more than 50 participants between January 1985 and January 2008, the Diwadkar team set out to determine the likelihood of complications resulting from the use of transvaginal mesh.  Of the 3,425 cases the Diwadkar team reviewed, 433[2] patients required surgical “intervention not under general anesthesia,”[3] and 245[4] required “intervention under general anesthesia.”[5]  This creates a total of 608 patients that required surgical intervention to resolve complications of transvaginal mesh use.

Though transvaginal mesh is an effective means of organ reparation, the frequency with which surgical intervention is required is far too high.  Due to the fact that the manufacturers of transvaginal mesh products have failed to disclose the risks associated with the use of their products, coupled with the fact that over 1,000 adverse events related to transvaginal mesh have been reported to the United States Food and Drug Administration, many transvaginal mesh lawsuits are currently being filed.

If you or a loved one has used transvaginal mesh and experienced a complication such as vaginal mesh erosion, please do not hesitate to contact our team of transvaginal mesh lawyers for a free, no-obligation case consultation.

At your convenience, you may reach our offices by phone at (855) 452-5529 or by e-mail at justinian@dangerousdrugs.us.  If you are unsure whether you may have a case or would simply like more information, give us a call.  We are here to help.